KZIA Earnings & Financial Statements
Kazia Therapeutics Limited
$7.10
+$0.31(+4.57%)
39
Overall
60
Value
18
Tech
39
Quality
Market Cap
$105.58M
Volume
89.54K
52W Range
$4.86 - $17.40
Target Price
$29.80
KZIA earnings and financial statements: Kazia Therapeutics Limited's income statement, balance sheet and cash flow statement, annual and quarterly.
KZIA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.90M | $2.49M | - | - | $15.18M |
| Operating income | -$27.52M | -$28.45M | -$20.76M | -$24.76M | -$21.56M |
| EBITDA | -$21.51M | -$27.69M | -$18.87M | -$23.53M | -$5.11M |
| Net income | -$20.70M | -$29.29M | -$20.46M | -$25.01M | -$8.42M |
| EPS (diluted) | $-18.89 | $-50.78 | $-11.25 | $-19.00 | $-1750.00 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $6.06M | $21.59M | $28.08M | $34.96M | $58.09M |
| Total liabilities | $14.36M | $31.60M | $16.03M | $16.32M | $20.24M |
| Shareholders’ equity | -$8.30M | -$10.02M | $12.05M | $18.64M | $37.85M |
| Cash and equivalents | $4.34M | $1.66M | $5.24M | $7.36M | $27.59M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$13.28M | -$9.58M | -$15.16M | -$22.76M | -$9.11M |
| Free cash flow | -$13.28M | -$9.58M | -$15.16M | -$22.76M | -$9.11M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KZIA | $7.10 | +4.6% | 89.54K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kazia Therapeutics Limited Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW